HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Therapeutic effects of nandrolone and testosterone in adult male HIV patients with AIDS wasting syndrome (AWS): a randomized, double-blind, placebo-controlled trial.

AbstractPURPOSE:
We aimed to compare therapeutic effects of intramuscular (IM) nandrolone decanoate and IM testosterone enanthate in male HIV patients with AIDS wasting syndrome (AWS) with placebo control.
METHODS:
In this randomized, double-blind, placebo-controlled, 12-week trial, 104 patients with AWS who satisfied our inclusion criteria were randomly allotted in a 2:2:1 ratio to the 3 intervention groups: nandrolone, testosterone, and placebo. We administered 150 mg nandrolone and 250 mg testosterone (both IM, biweekly). The primary outcome measure was a comparison of absolute change in weight at 12 weeks between the nandrolone decanoate, testosterone, and placebo groups.
RESULTS:
Intent-to-treat analysis was done. The nandrolone group recorded maximum mean increase in weight (3.20 kg; post hoc P < .01 compared to placebo). Body mass index (BMI) of subjects in the nandrolone group had a significantly greater increase (mean = 1.28) compared to both testosterone (post hoc P < .05) and placebo (post hoc P < .01). Waist circumference and triceps skinfold thickness of patients on nandrolone showed similar results. Nandrolone also ensured a better quality of life. Patients with low testosterone level (<3 ng/mL) benefited immensely from nandrolone therapy, which increased their weight and BMI significantly compared to placebo (P < .05).
CONCLUSION:
Our trial demonstrates the superior therapeutic effects of nandrolone in male AWS patients, including the androgen deficient.
AuthorsPartha Sardar, Ayan Jha, Deeptarka Roy, Uddalak Majumdar, Pradipta Guha, Sabyasachi Roy, Ramtanu Banerjee, Amit Kumar Banerjee, Dipanjan Bandyopadhyay
JournalHIV clinical trials (HIV Clin Trials) 2010 Jul-Aug Vol. 11 Issue 4 Pg. 220-9 ISSN: 1528-4336 [Print] England
PMID20974577 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Testosterone
  • Nandrolone
  • testosterone enanthate
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
  • Nandrolone Decanoate
Topics
  • Adult
  • Body Composition (physiology)
  • Body Mass Index
  • Double-Blind Method
  • Follicle Stimulating Hormone (blood)
  • HIV (immunology)
  • HIV Infections (blood, drug therapy, immunology)
  • HIV Wasting Syndrome (blood, drug therapy, immunology, virology)
  • Humans
  • Injections, Intramuscular
  • Luteinizing Hormone (blood)
  • Male
  • Nandrolone (administration & dosage, analogs & derivatives)
  • Nandrolone Decanoate
  • Quality of Life
  • Skinfold Thickness
  • Testosterone (administration & dosage, analogs & derivatives)
  • Waist Circumference (physiology)
  • Weight Gain (drug effects, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: